This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Chronic pain management Remove Digital Health Remove Health Technology Remove Industry
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

NOVEMBER 25, 2023

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. EV to EBITDA: 12.5x Email lloyd@nelsonadvisors.co.uk

Pharmaceuticals 63
Pharmaceuticals Pain management Chronic pain management Mental health 63
article thumbnail

The next investment priorities for telehealth, RPM and connected health

Healthcare IT News - Telehealth

NOVEMBER 15, 2021

With the support of a new five-year VA grant in 2020, the research team is expanding the VA's teleneurology program, telepain program to provide chronic pain management via telehealth, and what the institute calls tele-GRACE to extend the reach of geriatric home and community-based care management via telehealth.

Connected Health 217
Connected Health Telehealth Telemedicine Leadership 217
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024